Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2007
10/04/2007US20070232613 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 3-nitro- or 3-alkoxycarbonyl-1-methyl-4-[4-thiophene-2-carbonyl)-piperazine-1-yl]-1H-quinolin-2-one; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
10/04/2007US20070232601 Vla-4 Inhibitor
10/04/2007US20070232586 Hydrazino-Substituted Heterocyclic Nitrile Compounds and Use Thereof
10/04/2007US20070232579 Nitrated Lipids and Methods of Making and Using Thereof
10/04/2007US20070232574 2-Oxothiazolidine 4-Carboxylic acid compounds for promoting desquamation of the skin
10/04/2007US20070232571 Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase
10/04/2007US20070232560 Treatment of skin with adenosine or adenosine analog
10/04/2007US20070232559 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
10/04/2007US20070232551 Treatment for Cardiovascular Disease
10/04/2007US20070232549 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
10/04/2007US20070232547 Two synthetic peptides for treatment and prevention of cancers
10/04/2007US20070232538 Uses of polypeptides
10/04/2007US20070231830 Using competitive binding assays to identify peptide modulators for signal transduction
10/04/2007US20070231404 Preparation derived from shark cartilage for treatment of diseases related to excessive PHF or excessive intracellular calcium
10/04/2007US20070231382 Pharmaceutical composition
10/04/2007US20070231376 Methods and compositions for modulating axonal outgrowth of central nervous system neurons
10/04/2007US20070231314 Polypeptides and compositions derived from the horny layer of the epidermis and its use
10/04/2007US20070231304 Prognostic factors for anti-hyperproliferative disease gene therapy
10/04/2007US20070231272 Process for Preparing Inhalable Powders
10/04/2007US20070231269 Analgesics
10/04/2007US20070231267 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
10/04/2007CA2645488A1 Formulations comprising rapamycin and methods using same for vascular permeability-related diseases or conditions
10/04/2007CA2645281A1 Triglyceride-lowering agent and hyperinsulinism-ameliorating agent
10/04/2007CA2635281A1 Method of using guava extract and composition including guava extract
10/03/2007EP1840215A1 Method of inhibiting telomerase activity and inhibitor
10/03/2007EP1840213A1 Target physiological function inactivator using photosensitizer-labeled fluorescent protein
10/03/2007EP1840208A1 Method of inducing differentiation of skeletal muscle cell
10/03/2007EP1840117A1 Mono- and disubstituted 3-propyl gamma-aminobutyric acids
10/03/2007EP1839675A1 Novel method of protecting ischemic cardiopathy
10/03/2007EP1839671A2 Attenuation of fibroblast proliferation
10/03/2007EP1839663A1 Blood cholesterol reducing oral composition
10/03/2007EP1839659A2 Chemicals compounds
10/03/2007EP1839657A2 A method for treating vascular headaches
10/03/2007EP1838351A2 Therapy inhalation involving antisense oligonucleotides for treating idiopathic pulmonary fibrosis
10/03/2007EP1737465A4 Composition and method of decreasing renal ischemic damage
10/03/2007EP1511722B1 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof
10/03/2007EP1463493B1 Methods of inducing ovulation-using a non-polypeptide camp level modulator
10/03/2007EP1456180B1 3-(2,4)dihydroxyphenyl-4-phenylpyrazoles and their medical use
10/03/2007EP1453909B1 Cereal beta glucan compositions, methods of preparation and uses thereof
10/03/2007EP1418921B1 Anti-tumour 2-alkoxyestradiol sulfamates
10/03/2007EP1368054B1 Using neural thread proteins to treat tumors
10/03/2007EP1355940B1 Urotensin-ii agonists and antagonists
10/03/2007EP1355631B1 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor
10/03/2007EP1351968B1 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus
10/03/2007EP1307458B1 Pyrrolotriazolopyrimidinone derivatives
10/03/2007EP1306093B1 Nerve regeneration promoters containing semaphorin inhibitor as the active ingredient
10/03/2007EP1304324B1 Serotonin reuptake inhibitors
10/03/2007EP1294378B1 Thrombopoietin mimetics
10/03/2007EP1042307B1 Aminothiazole inhibitors of cyclin dependent kinases
10/03/2007EP1023081B1 Use of recombinant human uteroglobin in treatment of fibrotic conditions
10/03/2007EP0735896B1 Parathyroid hormone formulation
10/03/2007EP0497828B2 A process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins
10/03/2007CN200954246Y Chinese medicine navel therapeutic plaster
10/03/2007CN101048406A Novel substituted imidazole derivatives
10/03/2007CN101048160A Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases
10/03/2007CN101045727A Inhibitors of tyrosine kinases
10/03/2007CN101045715A Heterocycle inhibitor for glycogen synthase kinase gsk-3
10/03/2007CN101045161A Modulators of P-selectin glycoprotein ligand 1
10/03/2007CN101045157A Method for preparing high activity, soluble, recombination human endothelial chalone injection
10/03/2007CN101044884A Method for prepairng feed additives containing yolk anti body
10/03/2007CN100340668C Improved chimeric glycoproteins and pseudotyped lentiviral vectors
10/03/2007CN100340575C Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
10/03/2007CN100340573C Heterocarpine, human GHRH-binding protein
10/03/2007CN100340556C Novel aryllimidazole derivatives, preparation and therapeutic used thereof
10/03/2007CN100340551C 4-(diarylmethyl)-1-piperazinyl derivatives
10/03/2007CN100340548C Novel arylheteroalkylamine derivatives
10/03/2007CN100340545C Tetralone derivatives as antitumor agents
10/03/2007CN100340294C Remedy for spinal injury containing interleukin-6 antagonist
10/03/2007CN100340293C Hair growth stimulants, percutaneous preparations and method of stimulating hair growth
10/03/2007CN100340288C Inhibitors for continuous activation of calcineurin
10/03/2007CN100340265C Sticky candy oral preparation
10/03/2007CN100340249C Medicine with chondriomere distortion preventing function
10/03/2007CN100340244C Method of implanting heavy method such as nobel metal, E.G. glod, and metal for use in implantation
10/02/2007US7277534 Communications system and method
10/02/2007US7276582 Control a mechanism of intracellular release of calcium, to control signal transmission in which intracellular calcium is involved; to control intracellular calcium release by carbonic anhydrase-related protein (CARP), to regulate or diagnose activity of IP3R
10/02/2007US7276533 Compositions useful for the treatment of pathologies responding to the activation of PPAR-gamma receptor
10/02/2007US7276528 Compounds for the inhibition of nitric oxide synthase
10/02/2007US7276527 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof
10/02/2007US7276518 For therapy of neuropathic or chronic pain
10/02/2007US7276517 Heterocyclic amide derivatives as inhibitors of glycogen phosphorylase
10/02/2007US7276514 Prevent tissue damage prevent stroke, headaches
10/02/2007US7276513 Steroidal compounds for inhibiting steroid sulphatase
10/02/2007US7276511 E.g., N-{2-(3,4-dichlorophenyl)-2-[(3,3-diphenylpropionyl)-methylamino]-4-{spiro[benzo(c)thiophene-1(3H),4'-piperidine]-(2S)-oxide}-1'-yl-butyl}-3,3,3-trifluoro-N-methyl-propionamide hydrochloride, NK-1 or NK-2 receptor antagonists; used to treat irritable bowel syndrome, pain, anxiety and vomiting
10/02/2007US7276509 Substance P; 2-(phenyl)-4-(3-oxo-piperazin-1-yl-)-piperidine-1-carboxylic acid; benzyl-methylamide; antagonists of the NK1 receptor; antidepressant, antiolytic; antiemetic
10/02/2007US7276503 Administration of optically pure (S,S) reboxetine, or a salt thereof; diminished adverse side effects
10/02/2007US7276500 Substituted amides, their preparation and use
10/02/2007US7276499 Sulfur-containing taxanes, specially covalently bonded to a cell binding agent for targeted delivey to specific cell populations
10/02/2007US7276496 Cyclic malonamides as inhibitors of Aβ protein protection
10/02/2007US7276495 Substituted lactams as inhibitors of Aβ protein production
10/02/2007US7276490 Administering to the cancer cell a pharmaceutical formulation of a nucleic acid encoding and expressing a prostacyclin synthase as an active ingredient and a nucleic acid encoding and expressing a cyclooxygenase-2
10/02/2007US7276475 Remodeling and glycoconjugation of peptides
10/02/2007US7276353 Nucleic acid encoding an infectious, nonpathogenic PCV1, which contains an immunogenic open reading frame gene of a pathogenic PCV2 in place of an ORF gene of the PCV1 nucleic acid molecule.
10/02/2007US7276252 Material handling of toxic drugs; multilayer forms
10/02/2007CA2413424C Substituted bicyclic derivatives for the treatment of abnormal cell growth
10/02/2007CA2412564C Purine derivatives
10/02/2007CA2401229C Aryl fused azapolycyclic compounds
10/02/2007CA2387357C Derivatives of pyrazolo[4,3-d]pyrimidin-7-ones which inhibit cyclic guanosine 3',5'-monophosphate phosphodiesterase
10/02/2007CA2378613C Selective iglur5 receptor antagonists for the treatment of migraine
10/02/2007CA2378369C Small molecules useful in the treatment of inflammatory disease
10/02/2007CA2289509C Novel compounds
1 ... 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 ... 1564